基本信息
浏览量:761
职业迁徙
个人简介
Dr. Ding’s laboratory is mainly focused on:(1) discovery and development of molecularly targeted anticancer drugs targeting tyrosine kinases,PI3K/mTOR pathway, epigenetic modulators and tumor angiogenesis regulators; (2) exploring molecular mechanisms of anticancer drugs, particularly signaling transduction and molecular basis of drug resistance; (3) characterizing genomics-based new targets for the proof of concept of novel cancer therapies; (4) discovery of biomarkers for molecularly targeted therapies.
研究兴趣
论文共 496 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Wenhao Du,Yuting Huang,Xiaoai Chen, Yue Deng,Yaoliang Sun, Hong Yang, Qiongyu Shi,Feifei Wu,Guobin Liu,He Huang,Jian Ding,Xun Huang,
Cell chemical biologyno. 1 (2024): 177-183.e17
Congying Pu, Yize Li,Yixian Fu, Yiyang Yan,Siyao Tao,Shuai Tang,Xiameng Gai, Ziyi Ding, Zhenjie Gan,Yingluo Liu,Siyuwei Cao,Ting Wang,
Advanced science (Weinheim, Baden-Wurttemberg, Germany)no. 11 (2024): e2304781-e2304781
Zhengrui Liu,Xiaodan Lyu, Jiaxu Chen, Benteng Zhang,Siman Xie, Yan Yuan,Li Sun,Shengtao Yuan,Hong Yu,Jian Ding, Mei Yang
Pharmaceuticalsno. 2 (2024): 224
Yingqiang Liu,Linjiang Tong, Mengge Zhang,Qi Zhang, Qiupei Liu,Fang Feng,Yan Li,Mengzhen Lai,Haotian Tang,Yi Chen,Meiyu Geng,Wenhu Duan,
Cancer communications (London, England)no. 3 (2024): 438-442
Journal of thoracic diseaseno. 2 (2023): 600-610
European Journal of Medicinal Chemistry (2023): 115453-115453
引用1浏览0WOS引用
1
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn